Comparison between Accretion Pharmaceuticals IPO and Patil Automation IPO.
Accretion Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Patil Automation IPO is a SME Bookbuilding proposed to list at NSE SME.
| Accretion Pharmaceuticals IPO | Patil Automation IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Jawa Capital Services Pvt.Ltd. | Seren Capital Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Mansi Share & Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Pharmaceuticals IPO is up to ₹28.26 Cr whereas the issue size of the Patil Automation IPO is up to ₹66.10 Cr. The final issue price of Accretion Pharmaceuticals IPO is ₹101.00 per share and of Patil Automation IPO is ₹120.00 per share.
| Accretion Pharmaceuticals IPO | Patil Automation IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹96.00 per share | ₹114.00 per share |
| Issue Price (Upper) | ₹101.00 per share | ₹120.00 per share |
| Issue Price (Final) | ₹101.00 per share | ₹120.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 27,98,400 shares | 55,08,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.26 Cr | up to ₹66.10 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,98,400 shares | 55,08,000 shares |
| Issue Size Total (Amount) | up to ₹28.26 Cr | up to ₹66.10 Cr |
Accretion Pharmaceuticals IPO opens on May 14, 2025, while Patil Automation IPO opens on Jun 16, 2025. The closing date of Accretion Pharmaceuticals IPO and Patil Automation IPO is May 16, 2025, and Jun 18, 2025, respectively.
| Accretion Pharmaceuticals IPO | Patil Automation IPO | |
|---|---|---|
| Anchor Bid Date | May 13, 2025 | Jun 13, 2025 |
| Issue Open | May 14, 2025 | Jun 16, 2025 |
| Issue Close | May 16, 2025 | Jun 18, 2025 |
| Basis Of Allotment (Tentative) | May 19, 2025 | Jun 19, 2025 |
| Initiation of Refunds (Tentative) | May 20, 2025 | Jun 20, 2025 |
| Credit of Share (Tentative) | May 20, 2025 | Jun 20, 2025 |
| Listing date (Tentative) | May 21, 2025 | Jun 23, 2025 |
| Anchor Lockin End date 1 | Jun 18, 2025 | Jul 19, 2025 |
| Anchor Lockin End date 2 | Aug 17, 2025 | Sep 17, 2025 |
Accretion Pharmaceuticals IPO P/E ratio is 21.29, as compared to Patil Automation IPO P/E ratio of 16.43.
| Accretion Pharmaceuticals IPO | Patil Automation IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Accretion Pharmaceuticals Limited Financial Information (Restated Consolidated)
| Patil Automation Limited Financial Information (Restated)Patil Automation Limited's revenue increased by 3% and profit after tax (PAT) rose by 49% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 94.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | 69.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.29 | 16.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹112.27 Cr. | ₹261.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 72.47% | 27.28% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.73% | 21.62% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.52 | 0.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.74 | ₹7.30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 72.47% | 21.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Pharmaceuticals IPO Retail Individual Investors (RII) are offered 12,22,800 shares while in Patil Automation IPO retail investors are offered 12,22,800 shares. Qualified Institutional Buyers (QIB) are offered 1,41,600 shares in Accretion Pharmaceuticals IPO and 11,01,600 shares in Patil Automation IPO.
| Accretion Pharmaceuticals IPO | Patil Automation IPO | |
|---|---|---|
| Anchor Investor Reserveration | 2,11,200 shares | 16,51,200 shares |
| Market Maker Reserveration | 1,47,600 shares | 2,92,800 shares |
| QIB | 1,41,600 shares | 11,01,600 shares |
| NII | 12,22,800 shares | 8,26,800 shares |
| RII | 12,22,800 shares | 19,28,400 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 27,98,400 shares | 55,08,000 shares |
Accretion Pharmaceuticals IPO subscribed 7.67x in total, whereas Patil Automation IPO subscribed 101.42x.
| Accretion Pharmaceuticals IPO | Patil Automation IPO | |
|---|---|---|
| QIB (times) | 12.14x | 82.92x |
| NII (times) | 4.28x | 258.18x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.54x | 44.77x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.67x | 101.42x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
